A B S T R A C T The solubility of triclinic calcium pyrophosphate dihydrate (CPPD) crystals was measured under varying conditions using '5Ca-labeled crystals, expressing solubility as micromoles per liter of 'Ca in solution. In a 0.1-M Tris-HCl buffer pH 7.4, the solubility of accurately sized CPPD crystals (37-20 um) was 60 iAM with maximal solubility being attained after about 8 h incubation at 37°C. Reduction in crystal size, decrease in pH, increase in ionic strength, Mg", citrate, and albumin all increased solubility. The most marked effects on solubility occurred when changing the calcium concentration or by enzymatic hydrolysis of inorganic pyrophosphate to orthophosphate. It was found that decreasing the ionized calcium level below 5 mg/100 ml resulted in a progressive enhancement of solubility. The observed solubility-enhancing effects of albumin could be explained solely on its calcium-binding ability and thereby, altered ionized calcium level. Diffusible calcium in synovial fluid was only 40% of the total calcium concentration, which means most joint fluids are normally near the critical concentration of 5 mg/100 ml of ionized calcium, below which solubility is enhanced. During surgery, especially parathyroidectomy, calcium levels fall, favoring dissolution of CPPD crystals. We speculate that the slight decrease in crystal size during dissolution frees them from their cartilaginous mold, resulting in a dose-dependent inflammatory reaction as they are "shed" into the joint space. Crystal shedding may be reinforced by the modest fall in joint fluid pH accompanying the inflammatory response.
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INTRODUCTION
Over a decade has passed since the initial association of calcium pyrophosphate dihydrate (CPPD)' crystals (Ca2P207) with a gout-like arthritis (1) . The articular inflammatory response includes the phagocytosis of intra-articular CPPD crystals by polymorphonuclear leukocytes with the subsequent release of lysosomal enzymes (1) (2) (3) . In many patients developing pseudogout, CPPD deposits are seen radiologically in both hyaline and fibrocartilage, and we have assumed that the crystals found in pseudogout joint fluid originate from these preformed deposits, but there is no definitive evidence on this point. The mechanism of this cartilaginous crystal deposition remains obscure, but is found more commonly in patients with hyperparathyroidism (4) and hemochromatosis (5) . More recently, elevated levels of inorganic pyrophosphate (PPi) have been found in the synovial fluid of patients with pseudogout (6) (7) (8) (9) ; during an acute episode, the PPi level is paradoxically reduced (9) .
As synovial fluid levels of PPi are higher than in plasma (6, 8, 9) , it is likely that PPs originates from within the joint. It could arise either from the dissolution of CPPD crystals or as a metabolic by-product of joint tissue metabolism. A knowledge of the solubility of CPPD crystals under various conditions and the rate of attaining equilibrium is of importance in resolving this issue. Moreover, some recent clinical observations (10) have indicated that factors increasing the solubility of CPPD crystals may be of importance as a "trigger" to the acute episode of pseudogout.
This present investigation is an extension of our previous work on CPPD crystal solubility (7) . 
MIETHODS
Gceeral. Acid-washed glassware or disposable plastic ware was used. All solutions were prepared in doubly distilled, deionized water. Salts used to prepare standard solutions were stored over anhydrous CaSO, in a vacuum desicator. All solutions were made up in either 0.1 M Tris-HCI buffer, pH 7.4, or a protein and calcium-free simulated plasnla, pH 7.4, (100 ml containing NaCl, 14 mg; K2HPO4, 13.4 mg; and NaH2PO, 2.7 miig) hereafter designated SP.
Incubation was performiied at 37CC in a Dubnoff metabolic shaker. All centrifuigation was (lone at 37°C in a Sorvall RC-2 centrifuge (Ivan Sorvall, Inc. Norwalk, Connl.) unless otherwise specified.
The following antimicrobial and antifungal agents were added to each 30 ml of solution: penicillin 10,000 U, streptomycin 100 mg, amphotericin B 2.5 mg.
Radioactive labeled CPPD crystals. Triclinic CPPD crystals wvere prepared in vitro by a modification of the method of Brown et al. (11) with the addition of 45Ca (New Englanid Nuclear, Boston, 'Mass.) to give a specific activity of approximately 0.1 paCi/nmg. After synthesis, the crystals were washed once in 0.1 M Tris-HCl buffer pH 7.4 for 2 h in a mass/volume ratio of 100 mg/2 ml.
After washing, the suspension wvas gently centrifuged, washed twice with a small volume of distilled water, and the crystal dried at 1800 C overnight before storing over anhydrous Ca2SO4 in a vacuum desiccator. This washing step effectively removed some highly soluble 45Ca surface contaminates that were present in small amounts.
The crystals were examined using compensated polarizing light microscopy to determine the uniformity of morphological and optical properties (12) . Previous X-ray diffraction studies had shown that crystals prepared in this way were biaxial, triclinic forms of CPPD (11) , and similar to natural crystals (13) .
Three accurately weighed sam)ples of ("Ca) CPPD crystals were dissolved in 0.5 ml of 0.5 N HCl and counted in 10 ml of Bray's solution. The mean specific activity of these standards was used throughout the study to translate counts per minute 4"Ca in the supernate into moles of Ca (and PPi) dissolved. Solubility was expressed as micromolar concentration of crystal-derived calcium.
Experimizenztal designi. The radioactive crystals were sieved to obtain crystals of three sizes: < 20 ,m, between 20 and 37 Am and > 37 ,um, (Endecotts Filters, London SW19).
In each experiment, a constant mass/volume (5 mg CPPD to 30 ml solution) wvas maintained, using a 100-ml conical flask containing a magnetic stirrer.
After the addition of the 45Ca CPPD, the flask was removed at intervals timed with a stopwatch and the contents magnetically stirred to a uniform suspension. 1 for 1 h in a plexiglas chamber of 1 ml capacity (Chemical Rubber Co. Apparatus, Cleveland, Ohio), separated by dialysis membrane (pore diameter 4.8 nm, Fisher Scientific Co., Pittsburgh, Pa.), and prepared according to the method of Brewer et al. (16) . 1-ml aliquot of the filtrate was dialyzed against 1 ml of SP for 1 h at 37°C. Prior '5Ca tracer experiments had shown free calcium equilibrated within 20 min.
The total calcium content in each chamber was measured by atomic absorption flame spectrophotometry and a 100-ul aliquot from each was counted for "5Ca.
10 synovial fluids (pH adjusted to 7.4) were similarly dialyzed, with the difference that 10 /41 of a "5Ca solution (20,000 cpm) was introduced into the SP side of the dialysis chamber. Again the distribution of bound and free calcium was determined both by atomic absorption and by radioactivity distribution.
Estimation of hydrolysis of PPi. This was routinely estimated in all experiments at 24 and 48 h. A 2-ml aliquot of the original solution was incubated separately with the addition of 100 /Al of 'P'P1 (New England Nuclear) with a specific activity of approximately 800 uCi/,gmol. Nonradioactive synthetic crystals of the same size, were added to provide an identical mass/volume ratio to that in the test flask. At specified times, 100 ,ul was taken from the "hydrolysis tube," put into ice, and thereafter, all procedures wxere performed in the cold. 100 I-L of 6 N perchloric acid was added to the 100-/,l aliquot, mixed, and centrifuged at 20,-000 g for 5 min at 4°C. To 100 gl of the supernate, 400 ,ul of cold P1 solution (144.2 mg anhydrous Na2HPO4/100 ml distilled water) and 1.0 ml of cold PP, solution (12.8 mg Na4P2O7 10 H20/100 ml distilled water) were added. Next 1.5 ml of reagent A (13.4 ml 5 g/100 ml ammonium molybdate + 3.6 ml 15 N H2S04 + 3.0 ml H20) was added and thoroughly mixed. 1 ml of this was added to 10 ml of 0.5 N HCI for counting (total counts T) using Cerenkov emission and a Packard Tri-Carb liquid scintillation counter, model 3320 (Packard Instrument Co., Inc., Downers Grove, Ill.). The efficiency of this counting technique was approximately 50%o. 2 ml of reagent B (four parts isobutanol + one part petroleum ether) was added to the remaining solution and mixed for exactly 1 min. After centrifugation at 1,000 g for 5 min, 1 ml from the upper layer (U) was counted in 10 ml of isobutanol, and 1 ml from the lower layer (L) was counted in 10 ml of 0.5 N HCl. By this method, PI was extracted into the isobutanol layer and the percentage of hydrolysis of PP, to Pi was calculated thus: percent hydrolysis PP1 = (cpm/ ml U X 0.8 X 100)/(cpm/ml U + L). The factor 0.8 was used to correct for the increased efficiency of counting in isobutanol.
In one experiment, the effect of hydrolysis was examined by adding approximately 2 U of inorganic pyrophosphatase ( A comparison of the solubility in Tris buffer of radioactive and nonradioactive CPPD crystals is illustrated in Fig. 2 . Both crystals achieved a similar final solubility, although the data for the nonradioactive CPPD crystals showed greater variability than did the corresponding values derived by counting "5Ca. The inset graph demonstrates the correlation between the two methods. The calculated specific activities were virtually constant, showing that the crystals were uniiformly labeled witl 45Ca.
In the isotopic exchange experimelnt in whichi 0.2 /Amol of 'Ca was allowed to "equilibrate" with 44.82
Mmol of CPPD crystals in 5 ml of Tris-HCl buffer for 48 h, the respective specific activities of the filtered CPPD crystals at 4, 9, 25, and 48 h were: 0. 19 Common ion effect. Ionized calcium concentration has a marked effect on solubility (Fig. 5 ). This experiment was done in SP and it is noted that the final solubility with no added calcium is 20 AI lower than in 0.1 M Tris-HCl buffer. In the range between 14 and 5 mg/100 ml, there is little change, but at lower concentrations there was a progressive increase in solubility.
The other common ion, PPi (Fig. 6 ), had unexpected effects on solubility; on an equimolar basis, up to a concentration of about 500 iNI, it had a more marked depressant effect on solubility than does Ca++ (Fig. 8) , it is seen that there was an apparent increase in solubility when compared to the same concentratiotn of Ca"+ in the absence of protein (Fig. 5) Table I . Wrhen the calcium is removed, the solubility increased markedly; the individual levels were those predicted from the data Fig. 5 , suggesting ionized calcium is the major determinant of CPPD crystal solubility. A similar phenomenon was seen when calcium was returned to the system, the final solubility was of the order of magnitude predicted from the data shown in Fig. 5 (Fig. 9) . Likewise citrate, a constituent of ACD (acid citarte dextrose) solution used in anticoagulating stored blood has an appreciable effect on solubility (Fig. 10) very small and constant the solubility product is given by the product (18):
[P207]. As we are measuring only the calcium concentration and by the law of mass action the PPi concentration is directly related: in our system K.P = [Ca]3. We have chosen to use the concentration of crystal-derived calcium as an index of solubility. This is obviously directly proportional to a derived K.p, but avoids making any of the above assumptions.
In those experiments in which there was added calcium in the incubation medium, the isoionic exchange of cold calcium with the 'Ca-labeled CPPD crystals will lead to some error in our calculated solubilities. In our isotope-exchange experiment, approximately 0.5% of calcium in the incubation medium exchanged with crystal-derived calcium. This implies that the true solubilities, in experiments containing exogenous calcium, (6) (7) (8) (9) , whereas, the ionized calcium level has a mean value of 3.5 mg/100 ml, this is 17-370 times greater (7) . MIoreover, much of the PPi in solution is in the form of MeP207 rather than as P20O7 where AMe+irefers to divalent cations (chiefly Mfg).
\Ve have shown that factors wvhiclh increase the solubility of CPPD crystals lead to an acute inflammatory episode of pseudogout (10) . WVe have termed this hypothetical process "crystal shedding" as CPPD crystals embedded in the articular cartilage become smaller until, loosened from their mold of matrix, they float freely into the joint cavity. Thus, the level of ionized calcium appears to be the most important regulator of CPPD dissolution. Within the range of 14-5 mg/100 ml there is relatively little effect on solubility, but with levels below 5 mg/100 ml, a rapid increase in solubility occurs.
It is tempting to speculate that postoperative attacks of pseudogout (19) , especially those after parathyroidectomy (20) For a patient undergoing a major surgical procedure, it has been shown the mean fall in ionized calcium is 73% (21) towards the end of the operation, returning slowly towards normal by the 4th postoperative day. Hence, a patient with a total plasma calcium of 10 mg/ 100 ml would have an ionized level of 6 mg/100 ml (assuming 60% of total is ionized in plasma) and this would be reflected by a synovial fluid-ionized calcium not greater than 4 mg/100 ml. If the plasma-ionized Ca++ level were reduced 73%, it would fall to 4.38 mg/100 ml and the corresponding synovial fluid level would drop to 2.92 mg/100 ml.
The increased CPPD crystal solubility during suirgery wxill be augmented by blood transfusion as shown by the experiments with citrate (the main constituent of anticoagulation mixtures used in stored blood) and miagnesiuimi (which is elevated in stored blood).
CPPD crystals take 12 h or more to reach equilibrium with common ioIns in the surrounding liquid. This is of importance relative to the origin of synovial fluid PP., which is higher than plasma PPi (8, 9) , suggesting local production. PP, could result from metabolism within car-tilage, subchondral bone, or synovial membrane cells, or from dissolution of CPPD crystals embedded in the cartilage or free in the synovial fluid.
Recent work has shlownI a mean turnover of 102,%/-h for the intra-articular PP, pool in chronic pseudogout and even higher values in more acute inflammation and in rlheumatoid joints (22) . Therefore, CPPD crystal dissolution does not contribute significantly to the PPi levels found in synovial fluid.
It has been suggested that a lower than normal activrity of inorganic pyrophosphatase in joint tissue could account for the higher PPi levels in the synovial fluid in pseudogout than in controls (23) . The case reported by O'Duffy (24) of coincident hypophosphatasia and pseudogout stlpports such a hypothesis, as there is good evidence that alkaline phosphatase is a pyrophosphatase (25) (26) (27) . A reduced activity of glucose-6-phosphate pyrophosphate phosphotransferase was found in the joint fluid of patients with both gout and pseudogout, as compared to rheumatoid arthritis (28) , while Russell and coworkers found a significantly reduced level of alkaline plhosphatase activity in pseudogout synovial fluid com157Ts pared to fluids from other patients with different types of arthritis, but we found no such difference in synovial fluid alkaline phosphatase levels (6) . Pyrophosphatase activity markedly augments the solubility of CPPD crystals. Theoretically, in the acute attack of pseudogout, neutrophil leukocyte phosphatases may be released and accelerate the shedding of crystals. However, actual synovial fluid PP1 hydrolysis rates in acute and chronic pseudogout showed no significant difference (22) . The decrease in joint fluid pH which accompanies inflammatory arthritis (29) may augment CPPD crystal dissolution and shedding. Crystal size may also be important, influencing crystal shedding as the smaller the crystals, the more rapid its dissolution rate (Fig. 3) .
